Ab­b­Vie’s Skyrizi helps more Crohn's pa­tients stay off steroids than J&J’s Ste­lara, PhI­II da­ta show

Ab­b­Vie’s Skyrizi has demon­strat­ed sig­nif­i­cant­ly high­er rates of steroid-free clin­i­cal and en­do­scop­ic re­mis­sion ver­sus ri­val John­son & John­son’s Ste­lara in a Phase III tri­al, help­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER